Atlas Trials

Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer

Clinical trial NCT00165854 · COMPLETED

Trial details

NCT number
NCT00165854
Sponsor
Eisai Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer (CRC)
Start date
2003-03-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.